Skip to content

Clinical Study to Investigate a New Mouthwash in Reducing Plaque and Helping Prevent Gum Problems on Dental Implants Over a 6-month Period of Product Use

A Clinical Study to Investigate a New Mouthwash Containing 0.075% CPC, and 0.1% Hyaluronic Acid and 0.28% Zinc Lactate as Compared to a Fluoride Mouthwash Containing 0.044% NaF in Reducing Plaque and Helping Prevent Gum Problems on Dental Implants Over a 6-month Period of Product Use

Status
Completed
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06770114
Enrollment
80
Registered
2025-01-13
Start date
2021-10-18
Completion date
2022-05-09
Last updated
2025-12-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gingivitis

Brief summary

The objective of this six-month clinical research study is to evaluate the clinical efficacy of a new mouthwash on helping prevent gum problems (gingival index scores ) in adults as compared to a control mouthwash.

Interventions

DRUGCetylpyridinium Chloride, Zinc Lactate and Hyaluronic Acid Mouthwash

0 .075 % cetylpyridinium chloride and 0 .28 % zinc lactate

DRUGPhosFlur Mouthwash

0 .044 % sodium fluoride

Sponsors

Colgate Palmolive
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
Yes

Inclusion criteria

* Availability for the six-month duration of the clinical research study. * Good general health. * Minimum of two dental implants (2 different quadrants ), each implant must have a restoration. * Initial mucositis index of at least 1 .0 as determined by the use of the Mombelli Modified Gingival Index. * Initial plaque index of at least 1 .5 as determined by the use of the Mombelli Modified Plaque Index. * Signed Informed Consent Form.

Exclusion criteria

* Presence of orthodontic bands. * Tumor (s ) of the soft or hard tissues of the oral cavity. * Advanced periodontal disease (purulent exudate, tooth mobility, and /or extensive loss of periodontal attachment or alveolar bone ) or peri-implantitis. * Five or more carious lesions requiring immediate restorative treatment. * Antibiotic use any time during the one-month period prior to entry into the study. * Participation in any other clinical study or test panel within the one month prior to entry into the study. * Dental prophylaxis during the past two weeks prior to baseline examinations. * History of allergies to oral care /personal care consumer products or their ingredients. * On any prescription medicines that might interfere with the study outcome. * An existing medical condition that prohibits eating or drinking for periods up to 4 hours. * History of alcohol or drug abuse. * Self-reported pregnant or lactating subjects

Design outcomes

Primary

MeasureTime frameDescription
Mombelli Modified Gingival IndexbaselineInitial mucositis index of at least 1.0 as determined by the use of the Mombelli Modified Gingival
Mombelli Modified Plaque IndexbaselineInitial plaque index of at least 1 .5 as determined by the use of the Mombelli Modified Plaque

Countries

Italy

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026